Houston-based medical device company, Hancock Jaffe Laboratories Inc. (HJLI), is dedicated to developing and manufacturing bioprosthetic medical devices that offer improved standards of care for treating cardiac and vascular diseases. With a focus on tissue-based solutions, HJLI's product pipeline currently includes the VenoValveÒ, a porcine based valve used to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based conduit designed for use in coronary artery bypass surgeries.